PI
UTHR icon

PFG Investments’s United Therapeutics UTHR Stock Holding History

PFG Investments’s Portfolio UTHR Stock Details UTHR Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$203K Buy
375
+25
+7% +$14.1K 0.01% 1168
2026
Q1 		$208K Buy
+350
New +$174K 0.01% 1050

Other funds holding UTHR

BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
ACA
Avoro Capital Advisors New York $11.1B AUM 207.82% 1-Year Est. Return
Vanguard Portfolio Management
Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
State Street
State Street Boston, Massachusetts $3.38T AUM 44.17% 1-Year Est. Return
Renaissance Technologies
Renaissance Technologies New York $72.6B AUM 54.88% 1-Year Est. Return
Wellington Management Group
Wellington Management Group Boston, Massachusetts $580B AUM 38.23% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
JT
Jupiter Topco New York $245B AUM
Norges Bank
Norges Bank Oslo, Norway $1T AUM

PFG Investments's UTHR Position: Q2 2026 in Review

PFG Investments increased its United Therapeutics (UTHR) stake by 7.1% in Q2 2026, buying an estimated $14.1K and bringing the position to 375 shares worth $203K. The position accounts for 0.01% of the portfolio, ranked #1168.

PFG Investments first reported a position in UTHR in Q1 2026 and has held it in 2 quarters since. The position peaked at $208K in Q1 2026. 884 funds tracked by Wall St. Rank hold UTHR as of Q2 2026.

  • PFG Investments held 375 shares of United Therapeutics worth $203K as of Q2 2026.
  • PFG Investments bought 25 United Therapeutics shares in Q2 2026, an estimated $14.1K.
  • United Therapeutics made up 0.01% of PFG Investments's portfolio in Q2 2026, its #1168 holding.
  • PFG Investments first reported a position in United Therapeutics in Q1 2026 and has held it in 2 quarters since.
  • PFG Investments's United Therapeutics position peaked at $208K in Q1 2026.
  • 884 funds tracked by Wall St. Rank held United Therapeutics as of Q2 2026.

Based on PFG Investments's 13F filing for Q2 2026, filed 23 Jul 2026.